← 產業報告目錄

Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-08-15頁數 330報告編號 MD3273

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global electrophysiology market is expected to reach USD 21.72 billion by 2030 from USD 12.55 billion in 2025, at a CAGR of 11.6% during the forecast period. The projected growth in the electrophysiology market is driven by technological advancements and increased research funding. The worldwide shift toward value-based care and early intervention also encourages wider adoption of diagnostic EP tools like implantable loop recorders and wearable ECG devices. Additionally, the growth of telehealth after COVID-19 has improved access to remote arrhythmia monitoring and follow-up care. Increased government investment in cardiac programs, rising investments from public-private partnerships, and ongoing integration of AI and robotic navigation systems further improve procedure efficiency and standardization. Overall, these factors are fueling strong global expansion of the electrophysiology market. “On the basis of product, the electrophysiology ablation catheters commanded the largest share in the electrophysiology market in 2024.” The electrophysiology market is categorized into several segments: electrophysiology laboratory devices, electrophysiology ablation catheters, electrophysiology diagnostic catheters, EP access products, and additional device types. The expansion of the electrophysiology (EP) ablation catheter sector is propelled by multiple factors. Notably, there is an increasing global incidence of atrial fibrillation (AF) and other cardiac arrhythmias, particularly within aging demographics, which heightens the demand for effective therapeutic interventions. Additionally, innovations in catheter technologies—such as contact force sensing, irrigated-tip designs, and pulsed field ablation—are enhancing safety, accuracy, and efficacy, thereby facilitating increased adoption among electrophysiologists. “On the basis of indication, the atrial fibrillation devices segment held the largest share in the electrophysiology market in 2024.” By product, the electrophysiology market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white (WPW) syndrome, and other indications. The expansion of the atrial fibrillation (AF) segment within the electrophysiology (EP) market is largely attributed to a convergence of demographic, lifestyle, clinical, and technological influences. The increasing global demographic of aging individuals, alongside rising rates of obesity, hypertension, diabetes, and sedentary behaviors, has led to a notable surge in AF prevalence. This growing burden of AF is driving heightened demand for EP diagnostics and therapeutic interventions. Moreover, significant advancements in EP procedural techniques, such as enhanced catheter ablation methods, state-of-the-art mapping systems, and sophisticated intracardiac imaging technologies, have markedly improved both the efficacy and safety profiles of interventions. These innovations are prompting clinicians to adopt ablation procedures earlier in the treatment continuum and with greater frequency, reflecting a paradigm shift in the management of AF. “By region, North America accounted for the largest market share in 2024.” The electrophysiology sector in North America is experiencing robust expansion, primarily driven by the rising incidence of cardiac arrhythmias, notably atrial fibrillation. This trend correlates with an aging demographic and a high prevalence of comorbidities such as obesity, diabetes, and hypertension. Consequently, there is an escalating demand for advanced diagnostic and therapeutic electrophysiological procedures. Recent innovations—including 3D electro-anatomical mapping, enhanced radiofrequency and cryoablation technologies, and the introduction of pulsed-field ablation—have markedly improved procedural accuracy, patient safety, and clinical outcomes. These advancements are facilitating greater integration of electrophysiology practices within standard cardiology workflows. “Asia Pacific to register the highest CAGR during the forecast period.” During the forecast period, the Asia Pacific (APAC) region is poised to experience considerable growth in the electrophysiology market. This region encompasses key markets such as India, China, Japan, Australia, South Korea, and Rest of Asia Pacific. The APAC electrophysiology market is witnessing a notable acceleration due to several interrelated factors. The escalating healthcare costs in major APAC countries—including China, India, Japan, and South Korea—are driving healthcare providers to adopt advanced medical technologies at an expedited pace. Enhanced healthcare infrastructure is facilitating this transition, allowing for greater accessibility to sophisticated electrophysiological devices. Moreover, the rising prevalence of cardiovascular diseases, attributable to demographic shifts such as aging populations, urbanization, and changing lifestyles, underscores the urgent need for effective diagnosis and treatment methodologies. Electrophysiology procedures, significantly relied upon for assessing and managing cardiac disorders, are consequently fueling demand for associated diagnostic and therapeutic devices within the region. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30% • By Designation: C-level–27%, Director-level–18%, and Others–55% • By Region: North America–50%, Europe–20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5% Key players in the electrophysiology market are Johnson & Johnson Services, Inc.(US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific Corporation (US), Japan Lifeline Co., Ltd (Japan), Stereotaxis, Inc.(US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), Teleflex Incorporated (US), Acutus Medical, Inc. (US), Merit Medical Systems (US), OSYPKA MEDICAL (Germany), Cook (US), Epmap-System (Germany), CathRx Ltd. (Australia), EP Solutions (Switzerland), CathVision (Denmark), TZ Medical, Inc. (US), APN Health, LLC (US), Lepu Medical Technology(Beijing)Co., Ltd (China), CardioFocus (US), Schwarzer Cardiotek (Germany), and Imricor (US). Study Coverage: The report analyzes the electrophysiology market and aims at estimating the market size and future growth potential of this market based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall pressure monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers • The report studies the electrophysiology market based on product, indication, end user, and region • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. • The report studies micro markets concerning their growth trends, prospects, and contributions to the global electrophysiology market. • The report forecasts the revenue of market segments with respect to five major regions. Key Benefits of Buying the Report: The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Electrophysiology market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment. The report provides insights on the following pointers: • Analysis of key drivers (technological innovations for advanced, effective, and easy-to-use electrophysiological devices; high geriatric population and increased prevalence of cardiovascular diseases; rising investments, funds, and grants for cardiac surgeries and electrophysiology; increasing cardiovascular disease incidence and procedural volume), restraints (high product cost and inadequate reimbursement in developing and under-resourced healthcare settings, unfavorable healthcare reforms in US); opportunities (substantial growth opportunities in emerging economies, popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services), and challenges (global shortage of skilled and experienced personnel) influencing the growth of the electrophysiology market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophysiology market. • Market Development: Comprehensive information about lucrative markets – the report analyses the Electrophysiology market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electrophysiology market. Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Johnson & Johnson Services, Inc. (US), Abbott (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), and Boston Scientific Corporation (US), among others.
目錄 Table of Contents
1 INTRODUCTION 30 1.1 STUDY OBJECTIVES 30 1.2 MARKET DEFINITION 30 1.3 STUDY SCOPE 31 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 31 1.3.2 INCLUSIONS & EXCLUSIONS 32 1.3.3 YEARS CONSIDERED 33 1.3.4 CURRENCY CONSIDERED 33 1.4 STAKEHOLDERS 33 1.5 SUMMARY OF CHANGES 34 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH APPROACH 35 2.1.1 SECONDARY DATA 35 2.1.1.1 Key secondary sources 36 2.1.1.2 Key data from secondary sources 36 2.1.2 PRIMARY DATA 37 2.1.2.1 Key primary sources 37 2.1.2.2 Objectives of primary research 37 2.1.2.3 Key data from primary sources 38 2.1.2.4 Breakdown of primaries 38 2.1.2.5 Key insights from primaries 39 2.2 MARKET SIZE ESTIMATION 40 2.2.1 REVENUE SHARE ANALYSIS 40 2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS) 42 2.2.3 TOP-DOWN APPROACH (UTILIZATION RATE AND ADOPTION PATTERN) 42 2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 43 2.3 GROWTH FORECAST 44 2.4 DATA TRIANGULATION 46 2.5 STUDY ASSUMPTIONS 47 2.6 RESEARCH IMITATIONS 47 2.6.1 SCOPE-RELATED LIMITATIONS 47 2.6.2 METHODOLOGY-RELATED LIMITATIONS 47 2.7 RISK ANALYSIS 48 3 EXECUTIVE SUMMARY 49   4 PREMIUM INSIGHTS 52 4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 52 4.2 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND COUNTRY 53 4.3 ELECTROPHYSIOLOGY MARKET: REGIONAL MIX 53 4.4 ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 54 4.5 ELECTROPHYSIOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS 54 5 MARKET OVERVIEW 55 5.1 INTRODUCTION 55 5.2 MARKET DYNAMICS 55 5.2.1 DRIVERS 56 5.2.1.1 Technological innovations for advanced, effective, and easy-to-use electrophysiological devices 56 5.2.1.1.1 Rising use of non-invasive cardiac mapping 56 5.2.1.1.2 Increasing use of improved intracardiac ablation systems 57 5.2.1.1.3 Rising use of MRI-guided ablation procedures 57 5.2.1.1.4 Increasing ultrasound guidance in electrophysiology labs 58 5.2.1.2 High geriatric population and increased prevalence of cardiovascular diseases 58 5.2.1.3 Rising investments, funds, and grants for cardiac surgeries and electrophysiology 59 5.2.1.4 Increasing cardiovascular disease incidence and procedural volume 60 5.2.2 RESTRAINTS 61 5.2.2.1 High product cost and inadequate reimbursement in developing and under-resourced healthcare settings 61 5.2.2.2 Unfavorable healthcare reforms in US 62 5.2.3 OPPORTUNITIES 63 5.2.3.1 Substantial growth opportunities in emerging economies 63 5.2.3.2 Popularity of ambulatory surgical centers offering cost-effective outpatient electrophysiology services 64 5.2.4 CHALLENGES 64 5.2.4.1 Global shortage of skilled and experienced personnel 64 5.3 INDUSTRY TRENDS 65 5.3.1 INTEGRATION OF DIGITAL TECHNOLOGIES, ARTIFICAL INTELLIGENCE, AND REMOTE MONITORING IN ELECTROPHYSIOLOGY 65 5.3.2 ROBOTIC-ASSISTED ABLATION AND NAVIGATION TECHNOLOGIES FOR BETTER TRACTION IN ELECTROPHYSIOLOGY 65 5.4 TECHNOLOGY ANALYSIS 66 5.4.1 KEY TECHNOLOGIES 66 5.4.1.1 3D mapping and navigation systems 66 5.4.1.2 Cryoablation and radiofrequency ablation technologies 67 5.4.2 COMPLEMENTARY TECHNOLOGIES 67 5.4.2.1 Cardiac imaging technologies 67 5.4.2.2 Robotic navigation systems 67 5.4.3 ADJACENT TECHNOLOGIES 68 5.4.3.1 AI-enabled intravascular optical coherence tomography (OCT) 68 5.4.3.2 AI-driven view guidance in intra-cardiac echocardiography (ICE) 68 5.5 PORTER’S FIVE FORCES ANALYSIS 68 5.5.1 INTENSITY OF COMPETITIVE RIVALRY 69 5.5.2 BARGAINING POWER OF BUYERS 70 5.5.3 BARGAINING POWER OF SUPPLIERS 70 5.5.4 THREAT OF SUBSTITUTES 70 5.5.5 THREAT OF NEW ENTRANTS 70 5.6 KEY STAKEHOLDERS & BUYING CRITERIA 71 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 71 5.6.2 KEY BUYING CRITERIA 72 5.7 REGULATORY ANALYSIS 72 5.7.1 REGULATORY FRAMEWORK 72 5.7.1.1 North America 73 5.7.1.1.1 US 73 5.7.1.1.2 Canada 74 5.7.1.2 Europe 74 5.7.1.3 Asia Pacific 75 5.7.1.3.1 Japan 75 5.7.1.3.2 China 76 5.7.1.3.3 India 76 5.7.1.4 Latin America 77 5.7.1.4.1 Brazil 77 5.7.1.5 Middle East & Africa 77 5.7.1.5.1 UAE 77 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 5.8 REIMBURSEMENT SCENARIO ANALYSIS 79 5.9 PATENT ANALYSIS 81 5.9.1 PATENT PUBLICATION TRENDS FOR ELECTROPHYSIOLOGY MARKET 81 5.9.2 LIST OF KEY PATENTS 83 5.10 TRADE ANALYSIS 84 5.10.1 IMPORT DATA FOR HS CODE 901890, 2020−2024 84 5.10.2 EXPORT DATA FOR HS CODE 901890, 2020−2024 85 5.11 PRICING ANALYSIS 85 5.11.1 INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022–2024 85 5.11.2 AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022–2024 86 5.12 KEY CONFERENCES & EVENTS, 2025−2026 87 5.13 UNMET NEEDS & END-USER EXPECTATIONS 88 5.14 VALUE CHAIN ANALYSIS 88 5.15 SUPPLY CHAIN ANALYSIS 90 5.16 ECOSYSTEM ANALYSIS 91 5.17 CASE STUDY ANALYSIS 92 5.17.1 JOHNSON & JOHNSON TO EXPAND CARTO SUITE AND LEVERAGE AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING 92 5.17.2 ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY 92 5.17.3 PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT 93 5.18 ADJACENT MARKET ANALYSIS 94 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94 5.20 INVESTMENT & FUNDING SCENARIO 94 5.21 IMPACT OF AI/GEN AI ON ELECTROPHYSIOLOGY MARKET 95 5.22 IMPACT OF 2025 US TARIFF ON ELECTROPHYSIOLOGY MARKET 95 5.22.1 KEY TARIFF RATES 96 5.22.2 PRICE IMPACT ANALYSIS 97 5.22.3 IMPACT ON COUNTRY/REGION 97 5.22.3.1 North America 97 5.22.3.1.1 US 97 5.22.3.2 Europe 98 5.22.3.3 Asia Pacific 98 5.22.4 IMPACT ON END-USE INDUSTRIES 99 5.22.4.1 Hospitals & clinics 99 5.22.4.2 Ambulatory surgery centers 99 6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 100 6.1 INTRODUCTION 101 6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES 102 6.2.1 3D MAPPING SYSTEMS 103 6.2.1.1 Development of alternative technologies to limit market growth 103 6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS 105 6.2.2.1 Increasing public-private funding for developing advanced novel recording systems to augment market growth 105 6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS 106 6.2.3.1 Cost-effectiveness and technological advancements to spur segment growth 106 6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS 108 6.2.4.1 Rising lifestyle- and age-related disorders to drive adoption for cardiac disease treatment 108 6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS 109 6.2.5.1 High incidence of cardiovascular disorders and availability of technologically advanced equipment to boost market growth 109   6.2.6 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS 111 6.2.6.1 Favorable reimbursement scenario to propel market growth 111 6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS 113 6.3.1 CRYOABLATION CATHETERS 114 6.3.1.1 Therapeutic advantages and better clinical studies to drive market growth 114 6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS 116 6.3.2.1 Technologically-advanced and safer catheters to drive adoption among healthcare professionals 116 6.3.3 MICROWAVE ABLATION (MWA) CATHETERS 118 6.3.3.1 Smaller diameter antennas, faster procedure times, and larger heating zones to aid market growth 118 6.3.4 LASER ABLATION CATHETERS 119 6.3.4.1 Launch of technologically-advanced laser ablation catheters to drive adoption in healthcare settings 119 6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 121 6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 122 6.4.1.1 Development of technologically-advanced fixed and steerable diagnostic catheters to favor market growth 122 6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 124 6.4.2.1 Advanced electrophysiology diagnostic catheters to improve patient outcomes and optimize surgical procedures 124 6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 125 6.4.3.1 Availability of advanced ultrasound catheters and focus on supportive regulatory frameworks to drive segment 125 6.5 ELECTROPHYSIOLOGY ACCESS DEVICES 126 6.5.1 LAUNCH OF ADVANCED ACCESS DEVICES TO ENHANCE EFFICIENCY DURING ABLATION CATHETER MAPPING AND POSITIONING 126 6.6 OTHER ELECTROPHYSIOLOGY PRODUCTS 128 7 ELECTROPHYSIOLOGY MARKET, BY INDICATION 129 7.1 INTRODUCTION 130 7.2 ATRIAL FIBRILLATION 130 7.2.1 DEVELOPMENT OF ADVANCED CARDIAC MAPPING SYSTEMS FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET 130 7.3 ATRIAL FLUTTER 132 7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATING ATRIAL FLUTTER TO PROPEL MARKET GROWTH 132 7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) 134 7.4.1 INCREASING EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR TREATMENT OF AVNRT TO AID MARKET GROWTH 134 7.5 WOLFF-PARKINSON-WHITE (WPW) SYNDROME 135 7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO AUGMENT MARKET GROWTH 135 7.6 OTHER INDICATIONS 137 8 ELECTROPHYSIOLOGY MARKET, BY END USER 139 8.1 INTRODUCTION 140 8.2 HOSPITALS & CARDIAC CENTERS 140 8.2.1 PRESENCE OF BETTER CATHETERIZATION AND ELECTROPHYSIOLOGY LABORATORIES IN HOSPITALS TO SUPPORT MARKET GROWTH 140 8.3 AMBULATORY SURGERY CENTERS 141 8.3.1 DEMAND FOR MINIMAL HOSPITAL STAYS AND HIGH INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH 141 8.4 OTHER END USERS 143 9 ELECTROPHYSIOLOGY MARKET, BY REGION 145 9.1 INTRODUCTION 146 9.2 NORTH AMERICA 147 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148 9.2.2 US 152 9.2.2.1 US to dominate North American electrophysiology market during forecast period 152 9.2.3 CANADA 156 9.2.3.1 Growing government research funding to support market growth 156 9.3 EUROPE 160 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 160 9.3.2 GERMANY 164 9.3.2.1 Rising prevalence of atrial fibrillation and associated arrhythmias to propel market growth 164 9.3.3 UK 168 9.3.3.1 High geriatric population and rise in cardiac diseases to fuel market growth 168 9.3.4 FRANCE 172 9.3.4.1 Favorable government healthcare policies and schemes to support market growth 172 9.3.5 ITALY 176 9.3.5.1 Rising incidence of cardiovascular diseases to drive adoption of electrophysiology devices 176 9.3.6 SPAIN 179 9.3.6.1 Rising number of cardiac ablation procedures to drive adoption of electrophysoiology products 179 9.3.7 REST OF EUROPE 182 9.4 ASIA PACIFIC 186 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 186 9.4.2 JAPAN 191 9.4.2.1 Favorable reimbursement scenario and presence of universal healthcare policies to boost market growth 191 9.4.3 CHINA 195 9.4.3.1 Growing geriatric population and rising prevalence of cardiovascular diseases to favor market growth 195 9.4.4 INDIA 199 9.4.4.1 Favorable government healthcare initiatives to support market growth 199 9.4.5 AUSTRALIA 202 9.4.5.1 Increasing target disease burden and rising government funding to spur market growth 202 9.4.6 SOUTH KOREA 205 9.4.6.1 Supportive government initiatives to drive market 205 9.4.7 REST OF ASIA PACIFIC 209 9.5 LATIN AMERICA 212 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 212 9.5.2 BRAZIL 216 9.5.2.1 Modernization of healthcare facilities to propel market growth 216 9.5.3 MEXICO 220 9.5.3.1 Favorable investment scenario for medical device manufacturers to fuel market growth 220 9.5.4 REST OF LATIN AMERICA 223 9.6 MIDDLE EAST & AFRICA 226 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 227 9.6.2 GCC COUNTRIES 231 9.6.2.1 Kingdom of Saudi Arabia 235 9.6.2.1.1 Rising number of private hospitals and increasing government financial support to fuel market growth 235 9.6.2.2 UAE 239 9.6.2.2.1 High clinical demand, increased government investment, and technological progress to aid market growth 239 9.6.2.3 Rest of GCC Countries 242 9.6.3 REST OF MIDDLE EAST & AFRICA 245 10 COMPETITIVE LANDSCAPE 249 10.1 INTRODUCTION 249 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 249 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ELECTROPHYSIOLOGY MARKET 249 10.3 REVENUE ANALYSIS, 2020–2024 251 10.4 MARKET SHARE ANALYSIS, 2024 251 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 254 10.5.1 STARS 254 10.5.2 EMERGING LEADERS 254 10.5.3 PERVASIVE PLAYERS 254 10.5.4 PARTICIPANTS 254   10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 256 10.5.5.1 Company footprint 256 10.5.5.2 Region footprint 256 10.5.5.3 Product footprint 257 10.5.5.4 Indication footprint 258 10.5.5.5 End-user footprint 258 10.6 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2024 259 10.6.1 PROGRESSIVE COMPANIES 259 10.6.2 RESPONSIVE COMPANIES 259 10.6.3 DYNAMIC COMPANIES 259 10.6.4 STARTING BLOCKS 259 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 261 10.6.5.1 Detailed list of key startups/SMEs 261 10.6.5.2 Competitive benchmarking of startups/SMEs 261 10.7 COMPANY VALUATION & FINANCIAL METRICS 262 10.7.1 FINANCIAL METRICS 262 10.7.2 COMPANY VALUATION 262 10.8 BRAND/PRODUCT COMPARISON 263 10.9 R&D ASSESSMENT OF KEY PLAYERS 264 10.10 COMPETITIVE SCENARIO 264 10.10.1 PRODUCT LAUNCHES & APPROVALS 264 10.10.2 DEALS 265 10.10.3 OTHER DEVELOPMENTS 266 11 COMPANY PROFILES 267 11.1 KEY PLAYERS 267 11.1.1 JOHNSON & JOHNSON SERVICES, INC. 267 11.1.1.1 Business overview 267 11.1.1.2 Products offered 268 11.1.1.3 Recent developments 271 11.1.1.3.1 Product launches and approvals 271 11.1.1.3.2 Deals 272 11.1.1.4 MnM view 272 11.1.1.4.1 Right to win 272 11.1.1.4.2 Strategic choices 272 11.1.1.4.3 Weaknesses & competitive threats 272 11.1.2 ABBOTT 273 11.1.2.1 Business overview 273 11.1.2.2 Products offered 274 11.1.2.3 Recent developments 275 11.1.2.3.1 Product launches 275 11.1.2.3.2 Deals 276 11.1.2.4 MnM view 276 11.1.2.4.1 Right to win 276 11.1.2.4.2 Strategic choices 276 11.1.2.4.3 Weaknesses & competitive threats 276 11.1.3 MEDTRONIC 277 11.1.3.1 Business overview 277 11.1.3.2 Products offered 278 11.1.3.3 Recent developments 280 11.1.3.3.1 Product approvals 280 11.1.3.3.2 Deals 280 11.1.3.4 MnM view 281 11.1.3.4.1 Right to win 281 11.1.3.4.2 Strategic choices 281 11.1.3.4.3 Weaknesses & competitive threats 281 11.1.4 KONINKLIJKE PHILIPS N.V. 282 11.1.4.1 Business overview 282 11.1.4.2 Products offered 283 11.1.4.3 Recent developments 284 11.1.4.3.1 Deals 284 11.1.4.4 MnM view 284 11.1.4.4.1 Right to win 284 11.1.4.4.2 Strategic choices 284 11.1.4.4.3 Weaknesses & competitive threats 284 11.1.5 GE HEALTHCARE 285 11.1.5.1 Business overview 285 11.1.5.2 Products offered 286 11.1.5.3 Recent developments 287 11.1.5.3.1 Product approvals and enhancements 287 11.1.5.3.2 Deals 287 11.1.5.4 MnM view 288 11.1.5.4.1 Right to win 288 11.1.5.4.2 Strategic choices 288 11.1.5.4.3 Weaknesses & competitive threats 288 11.1.6 BOSTON SCIENTIFIC CORPORATION 289 11.1.6.1 Business overview 289 11.1.6.2 Products offered 290 11.1.6.3 Recent developments 293 11.1.6.3.1 Product approvals 293 11.1.6.3.2 Deals 293   11.1.7 JAPAN LIFELINE CO., LTD. 294 11.1.7.1 Business overview 294 11.1.7.2 Products offered 295 11.1.8 STEREOTAXIS, INC. 297 11.1.8.1 Business overview 297 11.1.8.2 Products offered 298 11.1.8.3 Recent developments 298 11.1.8.3.1 Product approvals 298 11.1.8.3.2 Deals 298 11.1.9 MICROPORT SCIENTIFIC CORPORATION 299 11.1.9.1 Business overview 299 11.1.9.2 Products offered 300 11.1.9.3 Recent developments 301 11.1.9.3.1 Product approvals 301 11.1.9.3.2 Other developments 301 11.1.10 BIOTRONIK 302 11.1.10.1 Business overview 302 11.1.10.2 Products offered 302 11.1.10.3 Recent developments 303 11.1.10.3.1 Expansions 303 11.1.11 TELEFLEX INCORPORATED 304 11.1.11.1 Business overview 304 11.1.11.2 Products offered 305 11.1.11.3 Recent developments 306 11.1.11.3.1 Deals 306 11.1.12 ACUTUS MEDICAL, INC. 307 11.1.12.1 Business overview 307 11.1.12.2 Products offered 308 11.1.12.3 Recent developments 308 11.1.12.3.1 Product approvals 308 11.1.13 MERIT MEDICAL SYSTEMS 309 11.1.13.1 Business overview 309 11.1.13.2 Products offered 310 11.1.13.3 Recent developments 311 11.1.13.3.1 Deals 311 11.1.14 OSYPKA MEDICAL 312 11.1.14.1 Business overview 312 11.1.14.2 Products offered 312 11.1.15 COOK 314 11.1.15.1 Business overview 314 11.1.15.2 Products offered 314   11.2 OTHER PLAYERS 315 11.2.1 EPMAP-SYSTEM 315 11.2.2 CATHRX LTD. 315 11.2.3 EP SOLUTIONS 316 11.2.4 CATHVISION 316 11.2.5 TZ MEDICAL, INC. 317 11.2.6 APN HEALTH, LLC 318 11.2.7 LEPU MEDICAL TECHNOLOGY (BEIJING) CO.,LTD. 319 11.2.8 CARDIOFOCUS 319 11.2.9 SCHWARZER CARDIOTEK 320 11.2.10 IMRICOR 320 12 APPENDIX 321 12.1 DISCUSSION GUIDE 321 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 326 12.3 CUSTOMIZATION OPTIONS 328 12.4 RELATED REPORTS 328 12.5 AUTHOR DETAILS 329
圖表清單 List of Tables & Figures
TABLE 1 ELECTROPHYSIOLOGY MARKET: INCLUSIONS & EXCLUSIONS 32 TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021–2024 (UNIT OF USD) 33 TABLE 3 ELECTROPHYSIOLOGY MARKET: STUDY ASSUMPTIONS 47 TABLE 4 ELECTROPHYSIOLOGY MARKET: RISK ANALYSIS 48 TABLE 5 GLOBAL ANNUAL CARDIAC SURGICAL VOLUMES PER 100,000 POPULATION (2023) 59 TABLE 6 MAJOR FUNDING BY KEY ORGANIZATIONS, 2023–2024 60 TABLE 7 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES 69 TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 71 TABLE 9 KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY SYSTEMS 72 TABLE 10 US FDA: CLASSIFICATION OF MEDICAL DEVICES 73 TABLE 11 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73 TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2024) 74 TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY 75 TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES 76 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 18 ELECTROPHYSIOLOGY MARKET: CPT CODES 80 TABLE 19 ELECTROPHYSIOLOGY MARKET: LIST OF KEY PATENTS, 2025 83 TABLE 20 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020−2024 (USD THOUSAND) 84 TABLE 21 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020−2024 (USD THOUSAND) 85 TABLE 22 INDICATIVE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY KEY PLAYER, 2022–2024 (USD THOUSAND) 85 TABLE 23 AVERAGE SELLING PRICE TREND OF ELECTROPHYSIOLOGY PRODUCTS, BY REGION, 2022–2024 (USD THOUSAND) 86 TABLE 24 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025−DECEMBER 2026 87 TABLE 25 ELECTROPHYSIOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS 88 TABLE 26 CASE STUDY 1: JOHNSON & JOHNSON TO EXPAND CARTO SUITE FOR LEVERAGING AI FOR DECISION SUPPORT, VISUALIZATION, AND REMOTE DATA SHARING 92 TABLE 27 CASE STUDY 2: ABBOTT TO INTRODUCE ENSITE OMNIPOLAR TECHNOLOGY (OT) FOR ORIENTATION-INDEPENDENT MAPPING WITH PRECISE SIGNAL CLARITY 92 TABLE 28 CASE STUDY 3: PHILLIPS TO LAUNCH KODEX-EPD SYSTEM FOR ENABLING HIGH-RESOLUTION ANATOMICAL AND ELECTRICAL MAPPING WITHOUT DIRECT CATHETER CONTACT 93 TABLE 29 ELECTROPHYSIOLOGY MARKET: IMPACT OF AI/GEN AI 95 TABLE 30 US ADJUSTED RECIPROCAL TARIFF RATES 96 TABLE 31 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ELECTROPHYSIOLOGY PRODUCTS 97 TABLE 32 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 101 TABLE 33 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 102 TABLE 34 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 35 3D MAPPING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 36 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 37 RADIOFREQUENCY (RF) ABLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 38 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 39 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 40 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 41 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 113 TABLE 42 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 43 CRYOABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 44 RADIOFREQUENCY (RF) ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 45 COMPARISON BETWEEN RADIOFREQUENCY ABLATION AND MICROWAVE ABLATION (MWA) CATHETERS 118 TABLE 46 MICROWAVE ABLATION (MWA) CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 47 LASER ABLATION CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 48 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 121 TABLE 49 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 50 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 51 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 52 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 53 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 54 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 55 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 130 TABLE 56 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 57 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 58 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT), BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 59 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE (WPW) SYNDROME, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 60 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 61 ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 62 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 63 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 64 ELECTROPHYSIOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 65 ELECTROPHYSIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 66 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 67 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 149 TABLE 68 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 69 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS) 150 TABLE 70 NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 71 NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 72 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 152 TABLE 73 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 74 US: KEY MACROINDICATORS 153 TABLE 75 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 153 TABLE 76 US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 77 US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 78 US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 79 US: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 155 TABLE 80 US: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 81 CANADA: KEY MACROINDICATORS 157 TABLE 82 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 157 TABLE 83 CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 84 CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 85 CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 86 CANADA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 159 TABLE 87 CANADA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 88 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 89 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 90 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 91 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS) 162 TABLE 92 EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 93 EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 94 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 164 TABLE 95 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 96 GERMANY: KEY MACROINDICATORS 165 TABLE 97 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165 TABLE 98 GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 99 GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 100 GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 101 GERMANY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 167 TABLE 102 GERMANY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 168 TABLE 103 UK: KEY MACROINDICATORS 169 TABLE 104 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 105 UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 106 UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 107 UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 108 UK: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 171 TABLE 109 UK: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 110 FRANCE: KEY MACROINDICATORS 172 TABLE 111 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 112 FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 113 FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 114 FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 115 FRANCE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 175 TABLE 116 FRANCE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 117 ITALY: KEY MACROINDICATORS 176 TABLE 118 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 176 TABLE 119 ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 120 ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 121 ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 122 ITALY: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 178 TABLE 123 ITALY: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 124 SPAIN: KEY MACROINDICATORS 179 TABLE 125 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180 TABLE 126 SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 127 SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 128 SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 129 SPAIN: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 182 TABLE 130 SPAIN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 131 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 132 REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 133 REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 134 REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 135 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 185 TABLE 136 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 137 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 138 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 139 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 140 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS) 189 TABLE 141 ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 142 ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 143 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 191 TABLE 144 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 191 TABLE 145 JAPAN: KEY MACROINDICATORS 192 TABLE 146 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 192 TABLE 147 JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 148 JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 149 JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 150 JAPAN: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 194 TABLE 151 JAPAN: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 152 CHINA: KEY MACROINDICATORS 195 TABLE 153 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196 TABLE 154 CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 155 CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 156 CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 157 CHINA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 198 TABLE 158 CHINA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 198 TABLE 159 INDIA: KEY MACROINDICATORS 199 TABLE 160 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 161 INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 162 INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 163 INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 164 INDIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 201 TABLE 165 INDIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 166 AUSTRALIA: KEY MACROINDICATORS 202 TABLE 167 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 203 TABLE 168 AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 169 AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 170 AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 171 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 205 TABLE 172 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 173 SOUTH KOREA: KEY MACROINDICATORS 206 TABLE 174 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 206 TABLE 175 SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 176 SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 177 SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 178 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 208 TABLE 179 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 180 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 209 TABLE 181 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 182 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 183 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 184 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 211 TABLE 185 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 186 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 187 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 213 TABLE 188 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 189 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS) 214 TABLE 190 LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 191 LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 192 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 216 TABLE 193 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 216 TABLE 194 BRAZIL: KEY MACROINDICATORS 217 TABLE 195 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 217 TABLE 196 BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 197 BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 198 BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 199 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 219 TABLE 200 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 201 MEXICO: KEY MACROINDICATORS 220 TABLE 202 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 221 TABLE 203 MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 204 MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 205 MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 206 MEXICO: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 223 TABLE 207 MEXICO: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 208 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 224 TABLE 209 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 210 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 211 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 212 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 226 TABLE 213 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 226 TABLE 214 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION) 227 TABLE 215 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 228 TABLE 216 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 217 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, BY VOLUME, 2023–2030 (UNITS) 229 TABLE 218 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 219 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 220 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 230 TABLE 221 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 231 TABLE 222 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 223 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 232 TABLE 224 GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 225 GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 226 GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 227 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 234 TABLE 228 GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 235 TABLE 229 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 236 TABLE 230 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 231 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 232 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 233 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 238 TABLE 234 KINGDOM OF SAUDI ARABIA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 235 UAE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 239 TABLE 236 UAE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 237 UAE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 238 UAE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 239 UAE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 241 TABLE 240 UAE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 242 TABLE 241 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 243 TABLE 242 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 243 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 244 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 245 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 245 TABLE 246 REST OF GCC COUNTRIES: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 245 TABLE 247 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 246 TABLE 248 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 249 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 250 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 251 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023–2030 (USD MILLION) 248 TABLE 252 REST OF MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 248 TABLE 253 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET 249 TABLE 254 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION 252 TABLE 255 ELECTROPHYSIOLOGY MARKET: REGION FOOTPRINT 256 TABLE 256 ELECTROPHYSIOLOGY MARKET: PRODUCT FOOTPRINT 257 TABLE 257 ELECTROPHYSIOLOGY MARKET: INDICATION FOOTPRINT 258 TABLE 258 ELECTROPHYSIOLOGY MARKET: END-USER FOOTPRINT 258 TABLE 259 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 261 TABLE 260 ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 261 TABLE 261 ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 264 TABLE 262 ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2022–MAY 2025 265 TABLE 263 ELECTROPHYSIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 266 TABLE 264 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 267 TABLE 265 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 268 TABLE 266 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 271 TABLE 267 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–MAY 2025 272 TABLE 268 ABBOTT: COMPANY OVERVIEW 273 TABLE 269 ABBOTT: PRODUCTS OFFERED 274 TABLE 270 ABBOTT: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 275 TABLE 271 ABBOTT: DEALS, JANUARY 2022–MAY 2025 276 TABLE 272 MEDTRONIC: COMPANY OVERVIEW 277 TABLE 273 MEDTRONIC: PRODUCTS OFFERED 278 TABLE 274 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 280 TABLE 275 MEDTRONIC: DEALS, JANUARY 2022–MAY 2025 280 TABLE 276 KONINKIJKE PHILIPS N.V.: COMPANY OVERVIEW 282 TABLE 277 KONINKIJKE PHILIPS N.V.: PRODUCTS OFFERED 283 TABLE 278 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MAY 2025 284 TABLE 279 GE HEALTHCARE: COMPANY OVERVIEW 285 TABLE 280 GE HEALTHCARE: PRODUCTS OFFERED 286 TABLE 281 GE HEALTHCARE: PRODUCT APPROVALS AND ENHANCEMENTS, JANUARY 2022–MAY 2025 287 TABLE 282 GE HEALTHCARE: DEALS, JANUARY 2022–MAY 2025 287 TABLE 283 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 289 TABLE 284 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 290 TABLE 285 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 293 TABLE 286 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–MAY 2025 293 TABLE 287 JAPAN LIFELINE CO., LTD.: COMPANY OVERVIEW 294 TABLE 288 JAPAN LIFELINE CO., LTD.: PRODUCTS OFFERED 295 TABLE 289 STEREOTAXIS, INC.: COMPANY OVERVIEW 297 TABLE 290 STEREOTAXIS, INC.: PRODUCTS OFFERED 298 TABLE 291 STEREOTAXIS, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 298 TABLE 292 STEREOTAXIS, INC.: DEALS, JANUARY 2022–MAY 2025 298 TABLE 293 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 299 TABLE 294 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 300 TABLE 295 MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 301 TABLE 296 MICROPORT SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 301 TABLE 297 BIOTRONIK: COMPANY OVERVIEW 302 TABLE 298 BIOTRONIK: PRODUCTS OFFERED 302 TABLE 299 BIOTRONIK: EXPANSIONS: JANUARY 2022–MAY 2025 303 TABLE 300 TELEFLEX INCORPORATED: COMPANY OVERVIEW 304 TABLE 301 TELEFLEX INCORPORATED: PRODUCTS OFFERED 305 TABLE 302 TELEFLEX INCORPORATED: DEALS, JANUARY 2022–MAY 2025 306 TABLE 303 ACUTUS MEDICAL, INC.: COMPANY OVERVIEW 307 TABLE 304 ACUTUS MEDICAL, INC.: PRODUCTS OFFERED 308 TABLE 305 ACUTUS MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 308 TABLE 306 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 309 TABLE 307 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 310 TABLE 308 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2022–MAY 2025 311 TABLE 309 OSYPKA MEDICAL: COMPANY OVERVIEW 312 TABLE 310 OSYPKA MEDICAL: PRODUCTS OFFERED 312 TABLE 311 COOK: COMPANY OVERVIEW 314 TABLE 312 COOK: PRODUCTS OFFERED 314 TABLE 313 EPMAP-SYSTEM: COMPANY OVERVIEW 315 TABLE 314 CATHRX LTD.: COMPANY OVERVIEW 315 TABLE 315 EP SOLUTIONS: COMPANY OVERVIEW 316 TABLE 316 CATHVISION: COMPANY OVERVIEW 316 TABLE 317 TZ MEDICAL, INC.: COMPANY OVERVIEW 317 TABLE 318 APN HEALTH, LLC: COMPANY OVERVIEW 318 TABLE 319 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 319 TABLE 320 CARDIOFOCUS: COMPANY OVERVIEW 319 TABLE 321 SCHWARZER CARDIOTEK: COMPANY OVERVIEW 320 TABLE 322 IMRICOR: COMPANY OVERVIEW 320 FIGURE 1 ELECTROPHYSIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE 31 FIGURE 2 ELECTROPHYSIOLOGY MARKET: YEARS CONSIDERED 33 FIGURE 3 ELECTROPHYSIOLOGY MARKET: RESEARCH DESIGN 35 FIGURE 4 ELECTROPHYSIOLOGY MARKET: KEY DATA FROM SECONDARY SOURCES 36 FIGURE 5 ELECTROPHYSIOLOGY MARKET: KEY PRIMARY SOURCES (SUPPLY AND DEMAND SIDES) 37 FIGURE 6 ELECTROPHYSIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES 38 FIGURE 7 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 38 FIGURE 8 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION 39 FIGURE 9 ELECTROPHYSIOLOGY MARKET: INSIGHTS FROM INDUSTRY EXPERTS 39 FIGURE 10 ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (REVENUE SHARE ANALYSIS) 40 FIGURE 11 MARKET REVENUE ESTIMATION OF MEDTRONIC (2024) 41 FIGURE 12 ELECTROPHYSIOLOGY MARKET: SUPPLY-SIDE ANALYSIS 41 FIGURE 13 ELECTROPHYSIOLOGY MARKET: BOTTOM-UP APPROACH 42 FIGURE 14 ELECTROPHYSIOLOGY MARKET: TOP-DOWN APPROACH 42 FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ELECTROPHYSIOLOGY MARKET 44 FIGURE 16 ELECTROPHYSIOLOGY MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS), 2024 45 FIGURE 17 ELECTROPHYSIOLOGY MARKET: DATA TRIANGULATION METHODOLOGY 46 FIGURE 18 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 49 FIGURE 19 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION) 50 FIGURE 20 ELECTROPHYSIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50 FIGURE 21 ELECTROPHYSIOLOGY MARKET: REGIONAL SNAPSHOT 51 FIGURE 22 RISING INCIDENCE OF CARDIOVASCULAR DISORDERS TO DRIVE MARKET 52 FIGURE 23 US AND ELECTROPHYSIOLOGY ABLATION CATHETERS ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024 53 FIGURE 24 ASIA PACIFIC TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 53 FIGURE 25 CHINA AND INDIA TO ACCOUNT FOR HIGHEST GROWTH RATES FROM 2025 TO 2030 54 FIGURE 26 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 54 FIGURE 27 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 28 ELECTROPHYSIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 69 FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 71 FIGURE 30 KEY BUYING CRITERIA FOR ELECTROPHYSIOLOGY END USERS 72 FIGURE 31 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015–JUNE 2025) 82 FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR ELECTROPHYSIOLOGY PATENTS (JANUARY 2015–JUNE 2025) 83 FIGURE 33 ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS 89 FIGURE 34 ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS 91 FIGURE 35 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM ANALYSIS 91 FIGURE 36 ADJACENT MARKETS TO ELECTROPHYSIOLOGY MARKET 94 FIGURE 37 ELECTROPHYSIOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94 FIGURE 38 ELECTROPHYSIOLOGY MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024 95 FIGURE 39 ELECTROPHYSIOLOGY MARKET: GEOGRAPHIC SNAPSHOT 146 FIGURE 40 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 148 FIGURE 41 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 187 FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2020−2024) 251 FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ELECTROPHYSIOLOGY MARKET (2024) 252 FIGURE 44 ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 255 FIGURE 45 ELECTROPHYSIOLOGY MARKET: COMPANY FOOTPRINT 256 FIGURE 46 ELECTROPHYSIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 260 FIGURE 47 EV/EBITDA OF KEY VENDORS 262 FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 262 FIGURE 49 ELECTROPHYSIOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 263 FIGURE 50 ELECTROPHYSIOLOGY MARKET: R&D ASSESSMENT OF KEY PLAYERS, 2022–2024 264 FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 268 FIGURE 52 ABBOTT: COMPANY SNAPSHOT 274 FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT 278 FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 283 FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT 286 FIGURE 56 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 290 FIGURE 57 JAPAN LIFELINE CO., LTD.: COMPANY SNAPSHOT 295 FIGURE 58 STEREOTAXIS, INC.: COMPANY SNAPSHOT 297 FIGURE 59 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 300 FIGURE 60 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 305 FIGURE 61 ACUTUS MEDICAL, INC.: COMPANY SNAPSHOT 307 FIGURE 62 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 310

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們